Results 71 to 80 of about 168,547,723 (230)

Smaller is better: nanobodies meet NMR

FEBS Letters, EarlyView.
Nanobodies are single‐domain antigen‐binding fragments derived from camelid heavy chain antibodies. Their small size, high stability, and exceptional specificity make nanobodies uniquely useful probes for NMR studies of protein dynamics, transient conformational states, and protein–protein interactions.
Oleg Y. Dmitriev
wiley   +1 more source

Out-of-Field Dose to the Eye Lens and Cardiac Implantable Electronic Devices (CIEDs) during VMAT of the prostate

, 2018
Volumetric Modulated Arc Therapy (VMAT) is a new type of Intensity Modulated Radiation Therapy (IMRT) technique as it can deliver a more accurate shape of sculpted 3D dose distribution to the targeted tumour volume in a single 360 degree gantry rotation ...
Tina C Baradaran (20168160)
core  

Dose Calculation Accuracy of Radiotherapy Treatment Planning Systems in Out-of-Field Regions

Journal of Biomedical Physics and Engineering, 2019
no ...
Farhood B., Ghorbani M.
doaj  

Calculation of Organ Dose Distribution (in-field and Out-of-field) in Breast Cancer Radiotherapy on RANDO Phantom Using GEANT4 Application for Tomographic Emission (Gate) Monte Carlo Simulation

Journal of Medical Signals and Sensors
Introduction: Organ dose distribution calculation in radiotherapy and knowledge about its side effects in cancer etiology is the most concern for medical physicists.
Marziyeh Behmadi, Mohammad Taghi Bahreyni Toossi, Shahrokh Nasseri, Mohammad Ehsan Ravari, Mahdi Momennezhad, Hamid Gholamhosseinian, Mohammad Mohammadi, Sibusiso Mdletshe   +7 more
doaj   +1 more source

The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers

Molecular Oncology, EarlyView.
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce, Simone Bini, Marialuisa Sponziello, Giorgio Grani, Giulia Fiscon, Paola Paci, Lorenzo Farina, Rosa Falcone, Valentina Maggisano, Sebastiano Filetti, Cosimo Durante, Antonella Verrienti   +11 more
wiley   +1 more source

Hospitalization of Field Museum

, 1918
Memorandum specification completed by the architectural firm Graham, Anderson, Probst and White for the trustees of the Field Museum. The specification was developed to outline the construction and finishing work for converting the existing ...
Graham, Anderson, Probst and White
core  

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

Molecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Dosimetric evaluation in breast tumours: comparison of three techniques

Saúde & Tecnologia, 2015
Purpose – To compare the conventional technique, the technique of mixed energies and the technique field-in-field with mixed energies, checking the received dose in organs at risk and target volume.
João Marques, Stephania Bressan, Nicolas Mamboury, Ana Cravo Sá, Carina Marques Coelho, Fátima Monsanto   +5 more
doaj   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

Molecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis, Jack V. Mills, Wojciech Niedzwiedz, Valentine M. Macaulay   +3 more
wiley   +1 more source